ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
UK regulator accuses Concordia of overcharging NHS for thyroid drug
November 24, 2017The UK Competition and Markets Authority (CMA) has accused Canadian pharma company Concordia International of abusing its dominant position by increasing the price of a thyroid drug by about 6,000%. -
Canada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds
November 23, 2017Concordia International, the Canadian drug company, has overcharged the NHS by more than £100m in the past decade for a life-changing thyroid drug, according to Britain’s competition watchdog.
Pharma Sources Insight January 2025
